Clinical evaluation of norbolethone therapy in stunted growth and poorly thriving children.
D000293:Adolescent; D045930:Anabolic Agents / Q000008:administration & dosage; D001219:Aspartate Aminotransferases / Q000097:blood; D001827:Body Height / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D006801:Humans; D007659:Ketones / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D010919:Placebos; D011278:Pregnanes / Q000494:pharmacology / Q000627:therapeutic use*; D013223:Statistics as Topic
D045930:Anabolic Agents; D007659:Ketones; D010919:Placebos; D011278:Pregnanes; D001219:Aspartate Aminotransferases